Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Lifestyle Changes Through Exercise and Nutrition (LEAN)

4. Juni 2018 aktualisiert von: Robert L. Newton, Jr., Pennington Biomedical Research Center

The Lifestyle Changes Through Exercise and Nutrition (LEAN) Project

The goal of The LEAN project intervention is to promote weight loss, healthy dietary habits, increased physical activity, improved blood glucose and cholesterol, and weight related quality of life in obese African American adults through a sustainable, technology enhanced, church-based program.

Studienübersicht

Status

Abgeschlossen

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

The LEAN Project is a community-based weight loss program that is delivered through churches serving lower-income, obese, African American adults. The intervention will involve training community health coaches to deliver the intervention. These community health coaches will be individuals who are members of the church and who are willing to be trained on how to deliver behaviorally-based, empirically proven, lifestyle change interventions. These community health coaches will be trained by the staff at Pennington Biomedical, who have experience training and delivering these types of interventions. The community health coaches will deliver the intervention through their respective church after being trained. Weekly text messages will be sent to participants in order to supplement the intervention sessions and provide support. The primary aim is to determine if the trained community health coach church-based intervention will result in significant weight loss. Secondary aims will assess blood glucose, cholesterol, physical activity, food intake, and weight related quality of life.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

97

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

  • Vereinigte Staaten
    • Louisiana
      • Baton Rouge, Louisiana, Vereinigte Staaten, 70808
        • Pennington Biomedical Research Center

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 75 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • self-identify as African American
  • a member of a participating church
  • age 18-75 years old
  • BMI > 30
  • own a mobile phone with text message capabilities
  • at risk for diabetes (diagnosed nuclear family member or gestational diabetes) or diagnosed with type 2 diabetes
  • willing to provide written informed consent
  • willing to change diet, physical activity and weight
  • able to participate in face-face counselling sessions as scheduled
  • low to moderate cardiovascular disease risk

Exclusion Criteria:

  • currently participating in a weight loss program
  • currently using weight loss medication or have lost weight (>10 lbs in last year)
  • planning to move from the area within the next year
  • given birth within the past year, are currently pregnant or plan to become pregnant within the next year
  • planning to have bariatric surgery within 2 years
  • history of major depression, suicidal behavior or eating disorder
  • hospitalization for a mental disorder or substance abuse in the last year
  • have cancer or had cancer within the past 5 years.
  • serious heart problems such as arrhythmias, cardiomyopathy, congestive heart failure
  • stroke or heart attack in the last six months
  • high blood pressure [systolic ≥160, or diastolic ≥100]
  • chronic inflammatory conditions, including but not limited to severe arthritis, lupus, or inflammatory bowel disease
  • diseases that are life threatening or that can interfere with or be aggravated by exercise or weight loss
  • unwilling or unable to provide informed consent
  • physician's or principal investigator's decision to exclude

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Crossover-Aufgabe
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Weight loss intervention
Churches randomized to the intervention condition will receive the community health coach delivered church based intervention for 6 months followed by 6 months of weight maintenance.
Verhalten: Weight loss intervention
The intervention will involve utilizing trained community health coaches to deliver the weight loss intervention. There will be 10 group based sessions conducted at each church over 6 months. Session frequency will be 4 weekly sessions (4) for the first month, bimonthly sessions for 2 months (4) and monthly sessions for 2 months (2). The study is based upon weight loss strategies that have been utilized in the Diabetes Prevention Program. The group sessions will be augmented by utilizing text messages. The text messages will be delivered weekly and three types of messages will be delivered: 1) lesson content, 2) motivational, 3) behavioral prompts.
Experimental: Delayed Treatment Control Group
Churches in the delayed treatment control condition will receive information on various health topics relevant to African Americans, such as strokes, lupus, sickle cell, etc. via text message during the first six months. Participants in this group will not receive any behavioral strategies designed to alter weight, physical activity, or diet during this time. They will receive the community health coach delivered church based weight loss intervention after 6 months.
Verhalten: Weight loss intervention
The intervention will involve utilizing trained community health coaches to deliver the weight loss intervention. There will be 10 group based sessions conducted at each church over 6 months. Session frequency will be 4 weekly sessions (4) for the first month, bimonthly sessions for 2 months (4) and monthly sessions for 2 months (2). The study is based upon weight loss strategies that have been utilized in the Diabetes Prevention Program. The group sessions will be augmented by utilizing text messages. The text messages will be delivered weekly and three types of messages will be delivered: 1) lesson content, 2) motivational, 3) behavioral prompts.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Percent weight loss
Zeitfenster: Month 6 and Year 1
Percent weight loss will be calculated at 6 and 12 months.
Month 6 and Year 1

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Body Fat Percentage
Zeitfenster: Screening, Month 6 and Year 1
The participant's body fat percentage is measured using the portable Tanita Body Composition Analyzer (SC-240).
Screening, Month 6 and Year 1
Change in Blood Glucose
Zeitfenster: Screening, Month 6 and Year 1
The Alere Cholestech LDX® Analyzer is engineered to provide accurate, actionable, and readily accessible glucose testing results. The Cholestech uses fingerstick sampling and small sample size (40μL) that makes results less time consuming and easy to obtain.
Screening, Month 6 and Year 1
Change in Blood Pressure
Zeitfenster: Screening, Month 6 and Year 1
Blood pressure will be measured using an automatic blood pressure cuff (Omeron, Model BP710 or similar). Participants will rest for approximately 5 minutes prior to blood pressure measurement to ensure accurate at rest reading.
Screening, Month 6 and Year 1
Change in Food Intake
Zeitfenster: Screening, Month 6 and Year 1
The National Cancer Institute (NCI) fat screener estimates the percentage of energy from fat by asking patients to report the frequency of consuming specific foods over the past 12 months. A standard 7-item fruit and vegetable screener developed by the NCI and National 5 a Day Program grantees asks how often fruit and vegetables were consumed in the past month.
Screening, Month 6 and Year 1
Change in Physical activity
Zeitfenster: Screening, Month 6 and Year 1
The International Physical Activity Questionnaire (IPAQ) questionnaire is a self-report measure of physical activity. The metabolic equivalent task (MET) minutes in each domain of leisure time activity, that is, sedentary, light, moderate, and vigorous intensity, will be calculated. The IPAQ has been shown to be a reliable and valid measure of physical activity and has been sensitive to changes in physical activity resulting from intervention programs.
Screening, Month 6 and Year 1
Change in Quality of Life
Zeitfenster: Screening, Month 6 and Year 1
. Each participant's quality of life will be assessed using the Impact of Weight on Quality of Life Survey.
Screening, Month 6 and Year 1
Satisfaction Questionnaire
Zeitfenster: Month 6 and Year 1
Each participant's satisfaction with the different elements of the study, including the community health coaches, the intervention, and the text messages, will be measured using a questionnaire developed by the investigators.
Month 6 and Year 1
Change in Blood Cholesterol
Zeitfenster: Screening, Month 6 and Year 1
The Alere Cholestech LDX® Analyzer is engineered to provide accurate, actionable, and readily accessible cholesterol testing results. The Cholestech uses fingerstick sampling and small sample size (40μL) that makes results less time consuming and easy to obtain.
Screening, Month 6 and Year 1
Change in Pulse
Zeitfenster: Screening, Month 6 and Year 1
Pulse will be measured using an automatic blood pressure cuff (Omeron, Model BP710 or similar). Participants will rest for approximately 5 minutes prior to pulse measurement to ensure accurate at rest reading.
Screening, Month 6 and Year 1

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Pennington Biomedical Research Center

Ermittler

  • Hauptermittler: Robert L Newton, Jr., PhD, Pennington Biomedical Research Center

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. Juni 2016

Primärer Abschluss (Tatsächlich)

23. September 2017

Studienabschluss (Tatsächlich)

23. September 2017

Studienanmeldedaten

Zuerst eingereicht

7. Juli 2016

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

8. August 2016

Zuerst gepostet (Schätzen)

11. August 2016

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

6. Juni 2018

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

4. Juni 2018

Zuletzt verifiziert

1. Juni 2018

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Schlüsselwörter

Andere Studien-ID-Nummern

  • PBRC 2016-018

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Weight loss intervention

Suchen Sie nach ähnlichen Studien

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

CROs by country

CROs in Gabon

Bedingungen

Seltene Krankheiten

Drogeninterventionen

Nahrungsergänzungsmittel

Sponsor / Mitarbeiter

Standorte

Abonnieren